Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases
Clinical trial NCT05484583 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05484583
- Sponsor
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2024-08-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.